Renata (DHA:RENATA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


DHA:RENATA Renata PLC DHA:RENATA
83 GF Score
Price BDT446.30
GF Value BDT806.73
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Renata Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Renata's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

DHA:RENATA vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renata Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Renata's Margin of Safety % (DCF FCF Based) falls into.


DHA:RENATA
83GF Score
Renata PLC DHA:RENATA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Renata (DHA:RENATA) Overvalued in 2026?

Based on GuruFocus' analysis, Renata stock appears to be undervalued. The current stock price of BDT446.30 is trading 44.7% below its estimated GF Value™ of BDT806.73. GuruFocus considers Renata to be Significantly Undervalued.

Key valuation signals for DHA:RENATA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: BDT806.73 vs. price of BDT446.30 (44.7% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the DHA:RENATA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renata Business Description

Address Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
83GF Score

Get the complete analysis for DHA:RENATA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT446.30
Price
BDT806.73
GF Value